Dana-Farber Cancer Institute

2025–2026 · award

The mechanistic study of irisin-mediated melanoma inhibition

Mu A · Dana-Farber Cancer Institute · funded by American Cancer Society

2025–2027 · award

Characterizing dormant uveal melanoma cells from clinical biopsies

Rizwan Haq · Dana-Farber Cancer Institute · funded by Melanoma Research Alliance

100kOcular Oncology and Treatments

2025–2026 · award

Mitochondrial Protein Immunogenicity and Tumor Rejection

Pere Puigserver · Dana-Farber Cancer Institute · funded by American Cancer Society

297k

2025–2027 · award

Targeting Lineage Plasticity of RB1/TP53 Mutant Lung Cancer

Yixiang Li · Dana-Farber Cancer Institute · funded by American Cancer Society

217.5kLung Cancer Treatments and Mutations

2025 · grant · Medical Research

Single-molecule in situ protein sequencing via expansion microscopy

Nicholas Polizzi · Dana-Farber Cancer Institute · funded by W. M. Keck Foundation

$1.3M

2025 · fellowship · Klingenstein-Simons Fellowship Awards in Neuroscience

Klingenstein-Simons Fellowship Awards in Neuroscience - Xin Gu (2025)

Xin Gu · Dana-Farber Cancer Institute · funded by Esther A. and Joseph Klingenstein Fund

2025–2027 · award

Investigating the Neuronal Regulation of Radioresistance in Diffuse Midline Gliomas

Mariella Filbin · Dana-Farber Cancer Institute · funded by American Cancer Society

297kGlioma Diagnosis and Treatment

2025–2027 · award

Investigating the intersection of LINE-1 retrotransposition and DNA replication

Esin Isik · Dana-Farber Cancer Institute · funded by American Cancer Society

147.5kChromosomal and Genetic Variations

2025–2027 · award

EWS-FLI1-Driven Upregulation of UGT3A2 Unlocks Drug Sensitivity Pathway for Precision Medicine in Ewing Sarcoma

Olasunkanmi Olaoye · Dana-Farber Cancer Institute · funded by American Cancer Society

217.5k

2025–2027 · award

Contribution of lipid metabolic processes to the tumorigenic potential of BRAF fusion oncoprotein in pediatric gliomas

Sehyun Oh · Dana-Farber Cancer Institute · funded by American Cancer Society

217.5kCancer, Lipids, and Metabolism

2025–2027 · award

Innovative Trial for Understanding the Impact of Targeted Therapies in NF2 (INTUITT-NF2)

Lorenzo Trippa · Dana-Farber Cancer Institute · funded by Children's Tumor Foundation

2025–2028 · grant · PCRP

Reversibility and Therapeutic Targeting of Treatment-Emergent Neuroendocrine Prostate Cancer

Myles Brown · Dana-Farber Cancer Institute · funded by Congressionally Directed Medical Research Programs

$2.1M

2025–2027 · award

Institutional Research Grant

Jennifer Mack · Dana-Farber Cancer Institute · funded by American Cancer Society

360k

2025–2027 · award

Lipid-dependent regulation of oncogenic signaling in aggressive lymphomas

Magdalena Bachmann · Dana-Farber Cancer Institute · funded by American Cancer Society

147.5kCancer, Lipids, and Metabolism

2025–2028 · award

Investigating the Oncogenic Function of Aberrant RNAs in Melanoma

Swathy Babu · Dana-Farber Cancer Institute · funded by American Cancer Society

217.5k

2025–2029 · grant · OCRP

A Phase 1B Study of BCL-XL Degrader DT2216 Combined With Paclitaxel in Recurrent Platinum-Resistant Ovarian Cancer

Elizabeth Stover · Dana-Farber Cancer Institute · funded by Congressionally Directed Medical Research Programs

$1.6M

2025–2027 · research · Global Health

Dana-Farber Cancer Institute - To discover new adjuvants

Dana-Farber Cancer Institute · funded by Bill and Melinda Gates Foundation

$1.3M

2025–2026 · fellowship · Postdoctoral Fellowship

Delineating the p62 oligomerization-mediated muscle adaptation to exercise in heart failure-induced skeletal myopathy

Yu Lei · Dana-Farber Cancer Institute · funded by American Heart Association

$165.9kAutophagy in Disease and Therapy

2025–2027 · award

The CD101 pathway promotes T cell dysfunction in cancer and its blockade represents a novel line of immunotherapy

Apoorvi Chaudhri · Dana-Farber Cancer Institute · funded by American Cancer Society

217.5kCancer Immunotherapy and Biomarkers

2025–2027 · grant · OCRP

Advancing Preclinical Studies of Dual-Targeted Fine-Tuned Immune-Restoring (DFIR) CAR-T Cell Therapy to Achieve Cures of High-Grade Serous Ovarian Cancer

Wayne Marasco · Dana-Farber Cancer Institute · funded by Congressionally Directed Medical Research Programs

$778.1k

2025–2027 · grant · MRP

Molecular Pathways of Uveal Melanoma Dormancy

Rizwan Haq · Dana-Farber Cancer Institute · funded by Congressionally Directed Medical Research Programs

$711.8k

2025–2028 · award

Deciphering the combinatorial assembly and function of mSWI/SNF (BAF) chromatin remodelers in human cancer

Sangwoo Park · Dana-Farber Cancer Institute · funded by American Cancer Society

217.5kGenomics and Chromatin Dynamics

2025–2029 · grant · KCRP

Expanding the Targetable Tumor Antigen Repertoire of Renal Cell Carcinoma

Catherine Wu · Dana-Farber Cancer Institute · funded by Congressionally Directed Medical Research Programs

$1.4M

2025–2029 · grant · PRCRP

A Phase 2 Trial of Nab-Sirolimus in Patients With Progressing or Symptomatic Epithelioid Hemangioendothelioma

Michael Wagner · Dana-Farber Cancer Institute · funded by Congressionally Directed Medical Research Programs

$3.2M

2025–2026 · fellowship · Postdoctoral Fellowship

Itaconate as a novel regulator of metabolic disease

Gerard Pernes · Dana-Farber Cancer Institute · funded by American Heart Association

$156.6kAdipokines, Inflammation, and Metabolic Diseases

2025 · award · grant

Refinement and proof-of-concept testing of a "food is medicine" intervention for childhood cancer survivors

Dana-Farber Cancer Institute · funded by American Institute for Cancer Research

$82.5kChildhood Cancer Survivors' Quality of Life

2025–2026 · award

Melanoma Prognostication Using Integrated Digital Pathology and Genomics

David Liu · Dana-Farber Cancer Institute · funded by Melanoma Research Alliance

75kCutaneous Melanoma Detection and Management

2025–2028 · award

Physiological and druggable redox signaling governs T cell activation

Haruna Takeda · Dana-Farber Cancer Institute · funded by Human Frontier Science Program

2025–2028 · award

Molecular mechanisms of aberrant SOX9 activity in colorectal cancer

Nilay Sethi · Dana-Farber Cancer Institute · funded by American Cancer Society

946k

2025–2030 · research · R37

Biochemical Mechanism of HIV DNA Integration

Alan N. Engelman · Dana-Farber Cancer Institute · funded by National Institutes of Health

$819.6k

2025 · research · PCF Young Investigator Award

Dissecting the Significance of Immune Infiltration in Hormone Sensitive Prostate Cancer with Highly-Multiplexed Immunofluorescence

Jeremiah Wala · Dana-Farber Cancer Institute · funded by Prostate Cancer Foundation

2025 · research

Developing personalized treatment approaches for patients with inflammatory breast cancer

Filipa Lynce · Dana-Farber Cancer Institute · funded by Breast Cancer Research Foundation

2025 · fellowship · ASH Research Training Award for Fellows (RTAF): First Year Awardees

ASH Research Training Award for Fellows (RTAF) 2025: Benson George

Benson George · Dana-Farber Cancer Institute · funded by American Society of Hematology

2025 · training · HIP Fellow Award

HIP Fellow Award 2025: Miriam Osei

Miriam Osei · Dana-Farber Cancer Institute · funded by American Society of Hematology

2025 · fellowship · AACR-ALK Positive Lung Cancer Research Fellowship

Epigenetic Drivers of Resistance to Lorlatinib in Anaplastic Lymphoma Kinase-Positive Lung Cancer

Alice Tzeng · Dana-Farber Cancer Institute · funded by American Association for Cancer Research

2025 · career development · Young Investigator Award

Advancing spatial immunoprofiling and risk-stratification in high-grade prostate cancer through multiplexed immunofluorescence tissue imaging

Jeremiah Wala · Dana-Farber Cancer Institute · funded by Conquer Cancer Foundation

$50k

2025 · career development · Young Investigator Award

Elucidating the molecular mechanisms and clinical relevance of the ELF3-mediated secretory epithelial state in pancreatic cancer multi-drug treatment resistance

Dan Gui · Dana-Farber Cancer Institute · funded by Conquer Cancer Foundation

$50k

2025 · research · Advanced Clinical Research Award

Deciphering Mechanisms of Response to Trastuzumab Deruxtecan and Immunotherapy Combination in HER2 Expressing Stage III Inflammatory Breast Cancer

Filipa Lynce · Dana-Farber Cancer Institute · funded by Conquer Cancer Foundation

$450k

2025 · career development · Young Investigator Award

Functional Profiling of Richter’s Transformation

Nathalie Javidi-Sharifi · Dana-Farber Cancer Institute · funded by Conquer Cancer Foundation

$50k

2025 · research · The AACR-KidneyCAN Kidney Cancer Innovation and Discovery Grants

Phenotypic Screening for Small Molecule Inhibitors of Oncogenic TFE3 Fusions

Srinivas R. Viswanathan · Dana-Farber Cancer Institute · funded by American Association for Cancer Research